Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
New book illustrating disease pathways released
Posted on January 23rd, 2020 by Xuanyan Xu in Pharma R&D
Pathway models are critical to drug discovery and personalized medicine, as they help with analyzing the massive amounts of data and information that confront pharma researchers in today’s data-rich world. That’s why it’s more important than ever to gain a better understanding of molecular signaling biology and disease pathways. To that end, Elsevier has just published Disease Pathways: An Atlas of Human Disease Signaling Pathways.
Designed to provide much-needed illustrated reviews of the cellular mechanisms of human diseases, this new volume covers 42 common non-oncologic diseases, illustrating connections between the molecular causes of the disease and its symptoms. The book is expected to be a valuable reference for biochemists, biologists, medical professionals, students, and all who want to learn more about cellular and molecular mechanisms in human disease.
Disease Pathways was authored by a team of renowned scientists and experts, including Anastasia P. Nesterova, Eugene A. Klimov, Maria Zharkova, Sergey Sozin, Vladimir Sobolev, Natalia V. Ivanikova, Maria Shkrob and Anton Yuryev. Featuring more than 145 color illustrations, the disease pathways depicted in the book are based on computational models from Elsevier’s Disease Pathway Collection.
Get more details on Disease Pathways: An Atlas of Human Disease Signaling Pathways here.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Sr. Marketing Manager, Life Sciences Audience at Elsevier
- Dr. Anton Yuryev discusses pathways and precision medicine at PMWC
- What’s ahead for the Life Sciences industry?
- Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better
- The nature of evidence in aging research
- Assessing the State of the Genomic Revolution